These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Erythrocytes as carriers of chemotherapeutic agents for targeting the reticuloendothelial system. Lynch WE; Sartiano GP; Ghaffar A Am J Hematol; 1980; 9(3):249-59. PubMed ID: 6165240 [TBL] [Abstract][Full Text] [Related]
48. Can cancer chemotherapy enhance the malignant behaviour of tumours? McMillan TJ; Hart IR Cancer Metastasis Rev; 1987; 6(4):503-19. PubMed ID: 3327630 [TBL] [Abstract][Full Text] [Related]
49. The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia. Briski R; Garcia-Manero G; Kantarjian H; Ravandi F Ther Adv Hematol; 2023; 14():20406207231205429. PubMed ID: 37854355 [TBL] [Abstract][Full Text] [Related]
50. Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate? Georgescu L; Paget SA Drug Saf; 1999 Jun; 20(6):475-87. PubMed ID: 10392665 [TBL] [Abstract][Full Text] [Related]
51. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs. Bartsch H; Tomatis L Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827 [TBL] [Abstract][Full Text] [Related]
52. In vitro genotoxic activities of fibrous erionite. Poole A; Brown RC; Turver CJ; Skidmore JW; Griffiths DM Br J Cancer; 1983 May; 47(5):697-705. PubMed ID: 6303378 [TBL] [Abstract][Full Text] [Related]
53. Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites. Barbi G; Steinbach P; Vogel W Hum Genet; 1984; 68(4):290-4. PubMed ID: 6239815 [TBL] [Abstract][Full Text] [Related]
54. Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine. Bouck N; Kokkinakis D; Ostrowsky J Mol Cell Biol; 1984 Jul; 4(7):1231-7. PubMed ID: 6209558 [TBL] [Abstract][Full Text] [Related]
55. Growth control variant cell line having increased serum requirement and decreased response to platelet-derived growth factor: reversion by 5-azacytidine. Straus DS; Coppock DL J Cell Biol; 1984 Nov; 99(5):1838-47. PubMed ID: 6208204 [TBL] [Abstract][Full Text] [Related]
56. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443 [TBL] [Abstract][Full Text] [Related]
57. A contact-insensitive subpopulation in Syrian hamster cell cultures with a greater susceptibility to chemically induced neoplastic transformation. Nakano S; Ueo H; Bruce SA; Ts'o PO Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5005-9. PubMed ID: 3860840 [TBL] [Abstract][Full Text] [Related]
58. Introduction and expression of the bacterial PaeR7 methylase gene in mammalian cells. Kwoh TJ; Kwoh DY; McCue AW; Davis GR; Patrick D; Gingeras TR Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7713-7. PubMed ID: 3463994 [TBL] [Abstract][Full Text] [Related]
59. Comparison of the Ames assay and the induction of sister chromatid exchanges: results with ten pharmaceuticals and five selected agents. Shubber EK; Jacobson-Kram D; Williams JR Cell Biol Toxicol; 1986 Sep; 2(3):379-99. PubMed ID: 3267457 [TBL] [Abstract][Full Text] [Related]
60. Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nyce J; Liu L; Jones PA Nucleic Acids Res; 1986 May; 14(10):4353-67. PubMed ID: 3086840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]